Preliminary clinical application of an aromatase inhibitor and a gonadotropin-releasing hormone agonist combination for inoperable endometrial cancer patients with comorbidities: case report and literature review

Releasing Hormone ◽

A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e61 ◽

2019 ◽

Vol 30 (4) ◽

Cited By ~ 4

Author(s):

Zhibo Zhang ◽

Huifang Huang ◽

Fengzhi Feng ◽

Jinhui Wang ◽

Ninghai Cheng

Keyword(s):

Endometrial Cancer ◽

Pilot Study ◽

Aromatase Inhibitor ◽

Obese Patients ◽

Releasing Hormone ◽

Fertility Sparing

Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed byin vitrofertilization program as management strategy for an infertile endometrial cancer patient: a case report

Gynecological Endocrinology ◽

10.3109/09513590.2012.738726 ◽

2012 ◽

Vol 29 (3) ◽

pp. 219-221 ◽

Cited By ~ 3

Author(s):

Giuseppe Nucera ◽

Vincenzo Dario Mandato ◽

Maria Carolina Gelli ◽

Stefano Palomba ◽

Giovanni Battista La Sala

Keyword(s):

Endometrial Cancer ◽

Case Report ◽

Cancer Patient ◽

Management Strategy ◽

Intrauterine Device ◽

Endometrial Cancer Patient ◽

Releasing Hormone ◽

Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients

10.26226/morressier.5912d9ebd462b802923862c7 ◽

2017 ◽

Author(s):

Dong-Yun Lee

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Ovarian Function ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Ovarian Protection ◽

Function Recovery ◽

Young Breast Cancer

Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4863-2 ◽

2018 ◽

Vol 171 (3) ◽

pp. 649-656 ◽

Cited By ~ 5

Author(s):

Dong-Yun Lee ◽

Yeon Hee Park ◽

Jeong Eon Lee ◽

DooSeok Choi

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Ovarian Function ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Function Recovery ◽

Young Breast Cancer

Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist

Fertility and Sterility ◽

10.1016/j.fertnstert.2006.09.010 ◽

2007 ◽

Vol 87 (6) ◽

pp. 1468.e9-1468.e12 ◽

Cited By ~ 15

Author(s):

Fuminori Kimura ◽

Kentaro Takahashi ◽

Koichi Takebayashi ◽

Mutsuko Fujiwara ◽

Nobuyuki Kita ◽

...

Keyword(s):

Aromatase Inhibitor ◽

Premenopausal Woman ◽

Concomitant Treatment ◽

Releasing Hormone ◽

Uterine Adenomyosis

Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Apoplexy in Treatment of Prostate Cancer: Case Report and Review of Literature

Endocrine Practice ◽

10.4158/ep.13.6.642 ◽

2007 ◽

Vol 13 (6) ◽

pp. 642-646 ◽

Cited By ~ 13

Author(s):

Kathleen Hands ◽

Andrea Alvarez ◽

Jan Bruder

Keyword(s):

Prostate Cancer ◽

Case Report ◽

Pituitary Apoplexy ◽

Cancer Case ◽

Prostate Cancer Case ◽

Review Of Literature ◽

Releasing Hormone ◽

Optimal Starting Time for Flutamide to Prevent Disease Flare in Prostate Cancer Patients Treated with a Gonadotropin-Releasing Hormone Agonist

Urologia Internationalis ◽

10.1159/000056592 ◽

2001 ◽

Vol 66 (3) ◽

pp. 135-139 ◽

Cited By ~ 24

Author(s):

Tomoyasu Tsushima ◽

Yasutomo Nasu ◽

Takashi Saika ◽

Yoshio Maki ◽

Masatoshi Noda ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Disease Flare ◽

Releasing Hormone ◽

Starting Time ◽

A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status

Fertility and Sterility ◽

10.1016/j.fertnstert.2008.09.064 ◽

2010 ◽

Vol 93 (1) ◽

pp. 192-198 ◽

Cited By ~ 99

Author(s):

Mohammad Ebrahim Parsanezhad ◽

Mina Azmoon ◽

Saeed Alborzi ◽

Abdoreza Rajaeefard ◽

Afsun Zarei ◽

...

Keyword(s):

Clinical Trial ◽

Aromatase Inhibitor ◽

Uterine Leiomyoma ◽

Controlled Clinical Trial ◽

Hormonal Status ◽

Randomized Controlled Clinical Trial ◽

Releasing Hormone ◽

Randomized Controlled

Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report

Fertility and Sterility ◽

10.1016/s0015-0282(16)55704-5 ◽

1993 ◽

Vol 59 (2) ◽

pp. 441-443 ◽

Cited By ~ 79

Author(s):

Jeffrey R. Nelson ◽

Stephen L. Corson

Keyword(s):

Case Report ◽

Releasing Hormone ◽

Term Management

Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study

Journal of Menopausal Medicine ◽

10.6118/jmm.2018.24.1.62 ◽

2018 ◽

Vol 24 (1) ◽

pp. 62

Author(s):

Sanam Moradan

Keyword(s):

Aromatase Inhibitor ◽

Uterine Leiomyoma ◽

Case Series ◽

Releasing Hormone ◽

Case Series Study ◽

Series Study